Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Kura Oncology Inc’s stock clocked out at $6.43, up 0.94% from its previous closing price of $6.37. In other words, the price has increased by $0.94 from its previous closing price. On the day, 0.77 million shares were traded. KURA stock price reached its highest trading level at $6.494 during the session, while it also had its lowest trading level at $6.2709.
Ratios:
To gain a deeper understanding of KURA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.71 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.88. For the most recent quarter (mrq), Quick Ratio is recorded 9.46 and its Current Ratio is at 9.46. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $27.
Stifel Downgraded its Buy to Hold on October 14, 2024, whereas the target price for the stock was revised from $26 to $19.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 21 ’25 when Hasnain Faheem sold 22,682 shares for $8.00 per share. The transaction valued at 181,456 led to the insider holds 23,983 shares of the business.
FAHEEM HASNAIN bought 30,000 shares of KURA for $235,500 on Mar 21 ’25. On Jan 28 ’25, another insider, DOYLE THOMAS JAMES, who serves as the SVP, Finance & Accounting of the company, sold 4,949 shares for $7.87 each. As a result, the insider received 38,958 and left with 88,193 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KURA now has a Market Capitalization of 519399968 and an Enterprise Value of -191546608. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.64 while its Price-to-Book (P/B) ratio in mrq is 1.22. Its current Enterprise Value per Revenue stands at -3.555 whereas that against EBITDA is 0.996.
Stock Price History:
The Beta on a monthly basis for KURA is 0.50, which has changed by -0.67277354 over the last 52 weeks, in comparison to a change of 0.07545352 over the same period for the S&P500. Over the past 52 weeks, KURA has reached a high of $23.48, while it has fallen to a 52-week low of $5.41. The 50-Day Moving Average of the stock is -8.97%, while the 200-Day Moving Average is calculated to be -52.12%.
Shares Statistics:
It appears that KURA traded 1.51M shares on average per day over the past three months and 1850610 shares per day over the past ten days. A total of 78.23M shares are outstanding, with a floating share count of 75.38M. Insiders hold about 6.68% of the company’s shares, while institutions hold 96.06% stake in the company. Shares short for KURA as of 1743379200 were 8802791 with a Short Ratio of 5.84, compared to 1740700800 on 9211838. Therefore, it implies a Short% of Shares Outstanding of 8802791 and a Short% of Float of 11.0.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
